| Reference |
Sentence |
Publish Date |
Extraction Date |
Species |
| Isobel Lavender, Iain S McGregor, Anastasia Suraev, Ronald R Grunstein, Camilla M Hoyo. Cannabinoids, insomnia, and other sleep disorders. Chest vol issue 2022 35537535 |
this critical review summarises the current evidence for the use of cannabinoids as a treatment for sleep disorders, and provides an overview of endocannabinoid modulation of sleep-wake cycles, and the sleep-modulating effects of plant-derived cannabinoids such as \xce\x94\xe2\x81\xb9-tetrahydrocannabinol (thc), cannabidiol (cbd), and cannabinol (cbn). |
2022-05-10 |
2022-05-12 |
Not clear |
| Lucas Busta, Ismail Dweikat, Shirley J Sato, Haolin Qu, Yong Xue, Bangjun Zhou, Lu Gan, Bin Yu, Tom Elmo Clemente, Edgar B Cahoon, Chi Zhan. Chemical and genetic variation in feral Cannabis sativa populations across the Nebraska climate gradient. Phytochemistry vol issue 2022 35436478 |
both male and female flower tissues produced cannabinoids, and, though the compounds were more abundant in female flower tissue, the primary cannabinoid in both was usually cannabidiol. |
2022-04-18 |
2022-04-25 |
Not clear |
| Albert Stuart Reece, Gary Kenneth Huls. Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 1 - continuous bivariate analysis. Archives of public health = Archives belges de sante publique vol 80 issue 1 2022 35354487 |
geotemporospatial and causal inferential epidemiological overview and survey of usa cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 1 - continuous bivariate analysis. |
2022-03-31 |
2022-04-14 |
Not clear |
| Albert Stuart Reece, Gary Kenneth Huls. Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 2 - categorical bivariate analysis and attributable fractions. Archives of public health = Archives belges de sante publique vol 80 issue 1 2022 35354495 |
geotemporospatial and causal inferential epidemiological overview and survey of usa cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 2 - categorical bivariate analysis and attributable fractions. |
2022-03-31 |
2022-04-14 |
Not clear |
| Albert Stuart Reece, Gary Kenneth Huls. Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 3 - spatiotemporal, multivariable and causal inferential pathfinding and exploratory analyses of prostate and ovarian cancers. Archives of public health = Archives belges de sante publique vol 80 issue 1 2022 35354499 |
geotemporospatial and causal inferential epidemiological overview and survey of usa cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 3 - spatiotemporal, multivariable and causal inferential pathfinding and exploratory analyses of prostate and ovarian cancers. |
2022-03-31 |
2022-04-14 |
Not clear |
| Liliana Soroceanu, Eric Singer, Pratiksha Dighe, Max Sidorov, Chandani Limbad, Aida Rodriquez-Brotons, Peter Rix, Rinette W L Woo, Lawrence Dickinson, Pierre-Yves Desprez, Sean D McAlliste. Cannabidiol inhibits RAD51 and sensitizes glioblastoma to temozolomide in multiple orthotopic tumor models. Neuro-oncology advances vol 4 issue 1 2022 35356807 |
cannabidiol (cbd), a nonpsychoactive cannabinoid with a low toxicity profile, has been shown to produce antitumor activity across cancers in part through selective production of reactive oxygen species (ros) in tumor cells. |
2022-03-31 |
2022-04-14 |
Not clear |
| Victor Longoria, Hannah Parcel, Bameelia Toma, Annu Minhas, Rana Zein. Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination. Biomedicines vol 10 issue 3 2022 35327341 |
neurological benefits, clinical challenges, and neuropathologic promise of medical marijuana: a systematic review of cannabinoid effects in multiple sclerosis and experimental models of demyelination. |
2022-03-25 |
2022-04-14 |
Not clear |
| Petr Jirasek, Alexandr Jusku, Vilim Simanek, Jana Frankova, Jan Storch, Jan Vace. Cannabidiol and periodontal inflammatory disease: A critical assessment. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia vol issue 2022 35332345 |
cannabidiol (cbd), a non-psychotropic cannabinoid produced by the genus cannabis, is a phytoceutical that activates the endocannabinoid system (ecs) through binding to cb1 and cb2 receptors. |
2022-03-25 |
2022-04-14 |
Not clear |
| Sarah Lord, Janet Hardy, Phillip Goo. Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer? Current treatment options in oncology vol issue 2022 35316478 |
focus has fallen on cannabidiol (cbd) as a potential treatment for a variety of symptoms in advanced cancer due to the lack of psychoactive side effects and the potential molecular mechanisms of action associated with this cannabinoid. |
2022-03-22 |
2022-04-14 |
Not clear |
| Katherine Walukevich-Dienst, Paige E Morris, Raymond P Tucker, Amy L Copeland, Julia D Buckne. Development and initial psychometric properties of the Cannabidiol Outcome Expectancies Questionnaire (CBD-OEQ). Psychological assessment vol issue 2022 35298216 |
cannabidiol (cbd), a nonpsychoactive cannabinoid, is used by many individuals to treat medical and mental health conditions, despite limited support for the efficacy of cbd for these conditions. |
2022-03-17 |
2022-04-14 |
Not clear |
| Svante Vikingsson, Ruth E Winecker, Edward J Cone, David J Kuntz, Brian Dorsey, Martin Jacques, Melanie Senter, Ronald R Flegel, Eugene D Haye. Prevalence of Cannabidiol, \\xce\\x949- and \\xce\\x948-Tetrahydrocannabinol and Metabolites in Workplace Drug Testing Urine Specimens. Journal of analytical toxicology vol issue 2022 35260906 |
parent \xce\x948-thc is a minor cannabinoid in marijuana, which appears to account for the typically low \xce\x948-thc-cooh concentrations (median 3.4 ng/ml) in most positive specimens. |
2022-03-09 |
2022-04-14 |
Not clear |
| Lin Li, Jin Feng, Lei Sun, Yao-Wei Xuan, Li Wen, Yun-Xia Li, Shuo Yang, Biao Zhu, Xiao-Yu Tian, Shuang Li, Li-Sheng Zhao, Rui-Jie Dang, Ting Jiao, Hai-Song Zhang, Ning We. Cannabidiol Promotes Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells in the Inflammatory Microenvironment via the CB2-dependent p38 MAPK Signaling Pathway. International journal of stem cells vol issue 2022 35220282 |
cannabidiol (cbd) is a natural cannabinoid with multiple biological activities, including anti-inflammatory and osteogenic potential. |
2022-02-27 |
2022-03-02 |
Not clear |
| Dmytro Isaev, Waheed Shabbir, Ege Y Dinc, Dietrich E Lorke, Georg Petroianu, Murat O. Cannabidiol Inhibits Multiple Ion Channels in Rabbit Ventricular Cardiomyocytes. Frontiers in pharmacology vol 13 issue 2022 35185573 |
cannabidiol (cbd), a major non-psychotropic cannabinoid found in the cannabis plant, has been shown to exert anti-nociceptive, anti-psychotic, and anti-convulsant effects and to also influence the cardiovascular system. |
2022-02-21 |
2022-02-23 |
Not clear |
| Shiori Takashina, Miki Takahashi, Koji Morimoto, Koichi Inou. LC-MS/MS Assay for the Measurement of Cannabidiol Profiling in CBD Oil from Japanese Market and Application for Convertible Tetrahydrocannabinol in Acetic Acid Condition. Chemical & pharmaceutical bulletin vol 70 issue 2 2022 35110438 |
cannabidiol (cbd), a major non-psychoactive cannabinoid, has a lot of attention due to its potential relaxing properties and led the trend in commercial cbd aroma/oral hemp seed oil from the japanese market. |
2022-02-03 |
2022-02-06 |
Not clear |
| Ronald J Ellis, Natalie Wilson, Scott Peterso. Cannabis and Inflammation in HIV: A Review of Human and Animal Studies. Viruses vol 13 issue 8 2021 34452386 |
cannabidiol may be particularly important as an anti-inflammatory cannabinoid. |
2022-02-02 |
2022-01-13 |
Not clear |
| D A Scott, H Dukka, D Saxen. Potential Mechanisms Underlying Marijuana-Associated Periodontal Tissue Destruction. Journal of dental research vol issue 2021 34515556 |
herein, we 1) examine insights obtained from the endocannabinoid system, 2) summarize animal models of exposure to cannabinoid receptor agonists and antagonists, 3) review the evidence suggesting that cannabis and cannabis-derived molecules exert a profound influence on components of the oral microbiome, and 4) assess studies indicating that marijuana and phytocannabinoids compromise the immune response to plaque. |
2022-02-01 |
2022-01-14 |
Not clear |
| D A Scott, H Dukka, D Saxen. Potential Mechanisms Underlying Marijuana-Associated Periodontal Tissue Destruction. Journal of dental research vol issue 2021 34515556 |
furthermore, we address how knowledge of cannabinoid influences in the oral cavity may be exploited to provide potential novel periodontal therapeutics, while recognizing that such medicinal approaches may be most appropriate for nonhabitual marijuana users. |
2022-02-01 |
2022-01-14 |
Not clear |
| Angela L Liang, Erin L Gingher, Jenell S Colema. Medical Cannabis for Gynecologic Pain Conditions: A Systematic Review. Obstetrics and gynecology vol 139 issue 2 2022 35104069 |
cannabis contains delta-9-tetrahydrocannabinol (thc) and cannabidiol (cbd), which are cannabinoids that bind to endocannabinoid system receptors. |
2022-02-01 |
2022-02-06 |
Not clear |
| Libor Uttl, Tom\\xc3\\xa1\\xc5\\xa1 Hlo\\xc5\\xbeek, Pavel Mare\\xc5\\xa1, Tom\\xc3\\xa1\\xc5\\xa1 P\\xc3\\xa1len\\xc3\\xad\\xc4\\x8dek, Hana Kubov\\xc3\\xa. Anticonvulsive Effects and Pharmacokinetic Profile of Cannabidiol (CBD) in the Pentylenetetrazol (PTZ) or N-Methyl-D-Aspartate (NMDA) Models of Seizures in Infantile Rats. International journal of molecular sciences vol 23 issue 1 2022 35008517 |
in spite of use of cannabidiol (cbd), a non-psychoactive cannabinoid, in pediatric patients with epilepsy, preclinical studies on its effects in immature animals are very limited. |
2022-01-31 |
2022-01-13 |
Not clear |
| Paolo Seccamani, Chiara Franco, Stefano Protti, Alessio Porta, Antonella Profumo, Diego Caprioglio, Stefano Salamone, Barbara Mannucci, Daniele Merl. Photochemistry of Cannabidiol (CBD) Revised. A Combined Preparative and Spectrometric Investigation. Journal of natural products vol 84 issue 11 2021 34668704 |
among them in recent years cannabidiol (cbd) has received the interest of pharmacology as the major nonpsychotropic cannabinoid with many potential clinical applications. |
2022-01-29 |
2022-01-13 |
Not clear |